Tag: train seat market growth

Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

#How Will The Asthma Drugs Market Valuation Change Between Now And 2029?#_x000D_

In recent years, the asthma drugs market has seen consistent growth. The market size is predicted to increase from $23.96 billion in 2024 to $24.93 billion in 2025, showing a compound annual growth rate (CAGR) of 4.0%. This upward trend in the historical period can be credited to environmental influences, an uptick in respiratory disorders, lifestyle modifications, and the development of healthcare infrastructure._x000D_

_x000D_

We anticipate a solid expansion in the asthma drugs market in the approaching years. The market is projected to scale up to “$31.38 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.9%. Factors contributing to this predicted growth include escalating air pollution, an expanding elderly population, improved awareness of healthcare, trends in personalized medicine, and innovations in biopharmaceuticals. During the forecast period, the market will be influenced by evolving trends such as the growth of small molecule therapies, the shift towards home-based asthma care, the implementation of biomarker-guided therapies, advancements in severe asthma therapies, and partnerships aimed at asthma research._x000D_

_x000D_

#Get A Free Sample Of The Report:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=11924&type=smp_x000D_

_x000D_

#Which Growth Drivers Are Shaping The Asthma Drugs Market Outlook?#_x000D_

The rise in asthmatic conditions is projected to spur the expansion of the asthma drug market. Asthma is a chronic illness that causes inflammation and swelling of the airways, leading to the narrowing of the passages that transport air from the mouth and nose to the lungs. Due to the escalating rates of asthma, there is a growing focus on the development of new drugs for the treatment of these conditions. For example, as reported by the Asthma + Lung UK, a UK-based charity that supports individuals with lung disorders, there were 1,146 recorded deaths linked to asthma in England in 2021. This figure experienced a rise in 2022, escalating to 1,236, depicting a worrisome increase in death rates related to the illness over the span of the year._x000D_

_x000D_

#How Is The Asthma Drugs Market Segmented Across Key Categories?#_x000D_

The asthma drugs market covered in this report is segmented – _x000D_

_x000D_

1) By Type Of Asthma: Allergic, Non-Allergic_x000D_

2) By Asthma Trigger Type: Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Nocturnal Asthma, Steroid-Resistant Asthma_x000D_

3) By Therapy: Preventive, Curative_x000D_

4) By Drug Class: Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs_x000D_

5) By End-User: Asthma Patients, COPD Patients_x000D_

_x000D_

Subsegments:_x000D_

1) By Allergic: Inhaled Corticosteroids (ICS), Leukotriene Receptor Antagonists (LTRAs), Monoclonal Antibodies _x000D_

2) By Non-Allergic: Short-Acting Beta Agonists (SABAs), Long-Acting Beta Agonists (LABAs), Oral Corticosteroids _x000D_

_x000D_

#What Key Trends Are Driving Growth In The Asthma Drugs Market?#_x000D_

Significant corporations in the asthma drugs market are prioritizing groundbreaking innovations such as fixed-dose combination (FDC) drugs to improve the efficiency of treatments and the compliance of patients. An FDC drug is a medication that bundles two or more active components into one dosage form like a tablet, capsule, or inhaler. For instance, Glenmark Pharmaceuticals, a pharmaceutical firm based in India, introduced Indamet, an FDC drug for uncontrolled asthma patients in India, in June 2022. This progressive treatment merges Indacaterol, a long-acting beta-agonist, with Mometasone Furoate, an inhaled corticosteroid. It is accessible in various strengths, featuring Indacaterol 150 mcg with Mometasone in doses of 80 mcg, 160 mcg, and 320 mcg. Indamet, which is planned for once-daily use, is aimed at adults and adolescents who are 12 years or older._x000D_

_x000D_

#Who Are The Leading Companies Driving The Asthma Drugs Market?#_x000D_

Major companies operating in the asthma drugs market include Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC., GlaxoSmithKline PLC., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Novartis International AG, Mylan N.V., Cipla Limited, Chiesi Farmaceutici S.p.A., Sun Pharmaceutical Industries Limited, Hikma Pharmaceuticals, Mundipharma International Limited, Lupin Limited, Glenmark Pharmaceuticals Limited, Hetero Drugs Limited, Alembic Pharmaceuticals Limited, Sunovion Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc., Beximco Pharmaceuticals Ltd, Innoviva Inc., Vectura Group, Circassia Group PLC, Pulmatrix Inc., Atopix Therapeutics Limited _x000D_

_x000D_

#Access The Complete Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report_x000D_

_x000D_

#Which Region Dominates The Asthma Drugs Market Today?#_x000D_

North America was the largest region in the asthma drugs market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Customize Your Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=11924&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Asthma Drugs Industry?

The size of the asthma medications market has been experiencing consistent growth over the past few years. The market, which was worth $23.96 billion in 2024, is anticipated to increase to $24.93 billion in 2025, indicating a compound annual growth rate (CAGR) of 4.0%. Factors contributing to this growth during the historical period include environmental elements, a rise in respiratory ailments, changes in lifestyle, and advancements in healthcare infrastructure.

The market for asthma medication is anticipated to experience significant expansion in the coming years. The market is projected to increase to “$31.38 billion in 2029, with a compound annual growth rate (CAGR) of 5.9%. This projected growth during the forecast period can be linked to factors such as escalating levels of air pollution, an aging population, heightened healthcare awareness, the trend towards personalized medicine, and innovations in biopharmaceuticals. The forecast period is projected to see trends like therapies using small molecules, at-home asthma care, treatments guided by biomarkers, advancements in therapies for severe asthma, and partnerships for asthma research.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11924&type=smp

#Which Factors Are Currently Driving The Growth Of The Asthma Drugs Market?

The asthma drug market is predicted to expand due to the high incidence of asthmatic conditions. Asthma is a chronic condition characterized by inflammation and swelling of the airways, which subsequently leads to a narrowing of the airways that transport air from the nose and mouth to the lungs. The rising number of asthma cases has led to a heightened focus on the discovery of new asthma medications for the treatment of such conditions. For example, Asthma + Lung UK, a charity based in England that aids people with respiratory issues, reported that in 2021, there were 1,146 asthma-related deaths in the country. This number troublingly increased to 1,236 in 2022, indicating a growing trend in deaths linked to the disease throughout the year.

How Is The Global Asthma Drugs Market Structured In Terms Of Segments?

The asthma drugs market covered in this report is segmented –

1) By Type Of Asthma: Allergic, Non-Allergic

2) By Asthma Trigger Type: Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Nocturnal Asthma, Steroid-Resistant Asthma

3) By Therapy: Preventive, Curative

4) By Drug Class: Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs

5) By End-User: Asthma Patients, COPD Patients

Subsegments:

1) By Allergic: Inhaled Corticosteroids (ICS), Leukotriene Receptor Antagonists (LTRAs), Monoclonal Antibodies

2) By Non-Allergic: Short-Acting Beta Agonists (SABAs), Long-Acting Beta Agonists (LABAs), Oral Corticosteroids

How Are Key Trends Driving Expansion In The Asthma Drugs Industry?

Leading firms in the asthma drugs market are prioritizing innovative advancements such as fixed-dose combination (FDC) drugs in order to improve the effectiveness of treatments and patient compliance. An FDC drug includes two or more active substances that are combined in one dosage form, like a capsule, tablet, or inhaler. Glenmark Pharmaceuticals, a pharmaceutical company based in India, as an example, launched a FDC drug named Indamet in June 2022 for patients whose asthma is not controlled. This innovative medication merges Indacaterol, a long-lasting beta-agonist, and Mometasone Furoate, an inhaled corticosteroid. It comes in a variety of strengths including Indacaterol 150 mcg with Mometasone at 80 mcg, 160 mcg, and 320 mcg, and is meant for once-daily usage, focusing on adolescents and adults aged twelve and above.

Who Are The Main Participants Shaping The Asthma Drugs Market Landscape?

Major companies operating in the asthma drugs market include Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC., GlaxoSmithKline PLC., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Novartis International AG, Mylan N.V., Cipla Limited, Chiesi Farmaceutici S.p.A., Sun Pharmaceutical Industries Limited, Hikma Pharmaceuticals, Mundipharma International Limited, Lupin Limited, Glenmark Pharmaceuticals Limited, Hetero Drugs Limited, Alembic Pharmaceuticals Limited, Sunovion Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc., Beximco Pharmaceuticals Ltd, Innoviva Inc., Vectura Group, Circassia Group PLC, Pulmatrix Inc., Atopix Therapeutics Limited

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

Which Region Currently Holds The Largest Share In The Asthma Drugs Market?

North America was the largest region in the asthma drugs market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11924&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Asthma Drugs Market From 2025 to 2029?

In the past few years, the market size for asthma drugs has seen a consistent increase. The market is predicted to expand from $23.96 billion in 2024 to $24.93 billion in 2025, with a compound annual growth rate (CAGR) of 4.0%. The historic growth can be credited to elements such as environmental factors, a rise in respiratory ailments, alterations in lifestyle, and the advancement in healthcare infrastructure.

The market size for asthma medication is projected to see robust expansion in the next several years. The market is expected to reach $31.38 billion in 2029, with a compound annual growth rate (CAGR) of 5.9%. Factors contributing to this projected growth include increasing levels of air pollution, an aging population, greater awareness of health care needs, the rise of personalized medicine, and advancements in biopharmaceuticals. Key trends expected throughout this period involve therapies based on small molecules, home-centered asthma treatment, therapies informed by biomarkers, progress in the treatment of severe asthma, and cooperative efforts in asthma research.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11924&type=smp

What Elements Are Contributing To Growth In The Asthma Drugs Market?

The escalating occurrence of asthma-related conditions is projected to drive the expansion of the asthma medication market in the future. Asthma is a chronic disease that leads to inflammation and swelling in airflow tracts, resulting in the airways carrying air from the nose and mouth to the lungs being narrowed. Due to the rise in asthma instances, the development and identification of new drugs to treat asthma disorders have notably increased. For example, in April 2024, Asthma + Lung UK, a charity based in England that assists individuals with lung conditions, reported that there were 1,146 asthma-related fatalities in England in 2021. This number increased to 1,236 in 2022, indicating an alarming rise in deaths linked to this condition throughout the year.

Which Segments Are Detailed In The Global Asthma Drugs Market Report?

The asthma drugs market covered in this report is segmented –

1) By Type Of Asthma: Allergic, Non-Allergic

2) By Asthma Trigger Type: Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Nocturnal Asthma, Steroid-Resistant Asthma

3) By Therapy: Preventive, Curative

4) By Drug Class: Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs

5) By End-User: Asthma Patients, COPD Patients

Subsegments:

1) By Allergic: Inhaled Corticosteroids (ICS), Leukotriene Receptor Antagonists (LTRAs), Monoclonal Antibodies

2) By Non-Allergic: Short-Acting Beta Agonists (SABAs), Long-Acting Beta Agonists (LABAs), Oral Corticosteroids

Which Emerging Trends And Strategic Shifts Are Shaping The Asthma Drugs Market?

The focus of major firms in the asthma drugs market is on developing innovations, particularly Fixed-Dose Combination (FDC) drugs, to increase the effectiveness of treatment and ensure better patient compliance. Distributed as a tablet, capsule, or inhaler, a fixed-dose combination (FDC) drug comprises two or more active substances delivered in a single dose. For example, Glenmark Pharmaceuticals, a pharmaceutical company from India, proclaimed in June 2022 the launch of Indamet, a fixed-dose combination (FDC) drug, designed for individuals in India suffering from uncontrolled asthma. This innovative solution fuses Indacaterol, a long-lasting beta-agonist, with Mometasone Furoate, an inhalable corticosteroid. It is available in different potencies, such as Indacaterol 150 mcg combined with Mometasone at 80 mcg, 160 mcg, and 320 mcg. Indamet, intended for daily use, is targeted at adults and adolescents who are 12 years and older.

Who Are The Key Contributors To Growth In The Asthma Drugs Market?

Major companies operating in the asthma drugs market include Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC., GlaxoSmithKline PLC., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Novartis International AG, Mylan N.V., Cipla Limited, Chiesi Farmaceutici S.p.A., Sun Pharmaceutical Industries Limited, Hikma Pharmaceuticals, Mundipharma International Limited, Lupin Limited, Glenmark Pharmaceuticals Limited, Hetero Drugs Limited, Alembic Pharmaceuticals Limited, Sunovion Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc., Beximco Pharmaceuticals Ltd, Innoviva Inc., Vectura Group, Circassia Group PLC, Pulmatrix Inc., Atopix Therapeutics Limited

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

Which Region Is Projected To Lead The Asthma Drugs Market By 2025?

North America was the largest region in the asthma drugs market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11924&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Asthma Drugs Market Size Changed, over the years?

The market size for asthma medications has seen significant growth in recent years. It’s expected to expand from $23.96 billion in 2024 to $25.17 billion in 2025, progressing at a compound annual growth rate (CAGR) of 5.0%. The rise in the previous periods can be attributed to environmental influences, a surge in respiratory ailments, changes in lifestyle, and advancements in healthcare infrastructure.

How Much Will the Asthma Drugs Market Be Worth in 2029?

The market size of asthma drugs is speculated to witness robust growth in the forthcoming years. By 2029, the market is projected to reach a value of $31.98 billion, increasing at a compound annual growth rate (CAGR) of 6.2%. Several factors such as escalating air pollution levels, an aging population, amplified awareness about healthcare, custom-made medicine trends, and innovations in the biopharmaceutical sector contribute to the growth during the prediction period. The forecast period also anticipates significant trends including therapies based on small molecules, asthma care based at home, therapies guided by biomarkers, advancements in the treatment of severe asthma, and collaborations in asthma research.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11924&type=smp

Which is the Largest Company in the Asthma Drugs Market?

Major companies operating in the asthma drugs market include Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC., GlaxoSmithKline PLC., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Novartis International AG, Mylan N.V., Cipla Limited, Chiesi Farmaceutici S.p.A., Sun Pharmaceutical Industries Limited, Hikma Pharmaceuticals, Mundipharma International Limited, Lupin Limited, Glenmark Pharmaceuticals Limited, Hetero Drugs Limited, Alembic Pharmaceuticals Limited, Sunovion Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc., Beximco Pharmaceuticals Ltd, Innoviva Inc., Vectura Group, Circassia Group PLC, Pulmatrix Inc., Atopix Therapeutics Limited

What Are the Main Market Drivers in the Asthma Drugs Industry?

The rising incidence of asthma-related conditions is predicted to boost the expansion of the asthma drug market. Asthma is a chronic condition that leads to inflammation and constriction of the air passages, leading to narrowed airways which transport air from the nose and mouth to the lungs. Due to a rise in the number of asthma diagnoses, there has been a growth in the discovery of new asthma pharmaceuticals aimed at handling these disorders. For example, in April 2024, Asthma + Lung UK, a charity based in England that aids individuals with lung issues, reported that in 2021, the number of deaths caused by asthma in England was documented at 1,146. The number increased in 2022, reaching 1,236, indicating a troubling rise in deaths related to the disease over the year.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11924&type=smp

How Is the Asthma Drugs Market Segments Structured?

The asthma drugs market covered in this report is segmented –

1) By Type Of Asthma: Allergic, Non-Allergic

2) By Asthma Trigger Type: Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Nocturnal Asthma, Steroid-Resistant Asthma

3) By Therapy: Preventive, Curative

4) By Drug Class: Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs

5) By End-User: Asthma Patients, COPD Patients

Subsegments:

1) By Allergic: Inhaled Corticosteroids (ICS), Leukotriene Receptor Antagonists (LTRAs), Monoclonal Antibodies

2) By Non-Allergic: Short-Acting Beta Agonists (SABAs), Long-Acting Beta Agonists (LABAs), Oral Corticosteroids

What Strategic Trends Are Transforming the Asthma Drugs Market?

Leading enterprises in the asthma drugs market are prioritizing the development of cutting-edge treatments such as fixed-dose combination (FDC) drugs to improve therapeutic efficiency and patient compliance. FDC drugs combine two or more active pharmaceutical ingredients into one single dosage form, such as a pill, capsule, or inhaler. For example, in June 2022, Glenmark Pharmaceuticals, an Indian pharmaceutical firm, introduced Indamet, an FDC drug for patients suffering from uncontrolled asthma in India. This ground-breaking treatment brings together Indacaterol, a long-acting beta2-agonist, and Mometasone Furoate, an inhaled corticosteroid, in various dosages, including Indacaterol 150 mcg mixed with Mometasone at 80 mcg, 160 mcg, and 320 mcg concentrations. The Indamet regimen, intended for daily use, is aimed at adults and teenagers aged 12 years and above.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

Which Global Regions Offer the Highest Growth in the Asthma Drugs Market?

North America was the largest region in the asthma drugs market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11924

This Report Delivers Insight On:

1. How big is the asthma drugs market, and how is it changing globally?

2. Who are the major companies in the asthma drugs market, and how are they performing?

3. What are the key opportunities and risks in the asthma drugs market right now?

4. Which products or customer segments are growing the most in the asthma drugs market?

5. What factors are helping or slowing down the growth of the asthma drugs market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Are the Primary Drivers Supporting the Market Growth of theAsthma Drugs Market?

The increasing incidence of asthma-related disorders is anticipated to boost the asthma drug industry’s expansion. Asthma is a chronic condition characterized by inflammation and swelling of the respiratory tract, causing airways to constrict, restricting air passage from the nose and mouth to the lungs. The rise in asthma incidents has triggered a wave of new asthma drugs being discovered to manage these health issues. For example, in April 2024, Asthma + Lung UK, a charity based in England that aids individuals with lung diseases, reported that in 2021, there were 1,146 asthma-related deaths in England. Unfortunately, this number rose to 1,236 in 2022, demonstrating a worrying increase in deaths linked with the disease over the year.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11924&type=smp

#What is the Projected CAGR for the Asthma Drugs Market Size from 2025 to 2034?

Over the past few years, there has been a robust expansion in the asthma drugs market. This market is projected to escalate from a value of $23.96 billion in 2024 to reach $25.17 billion in 2025, growing at a compound annual growth rate (CAGR) of 5.0%. The significant growth during the previous periods is due to environmental aspects, a rise in respiratory disorders, changes in lifestyles, and the development of healthcare infrastructure.

Anticipations for a solid upward trend in the asthma drugs market are high, as it is projected to reach a value of $31.98 billion in 2029 marking a compound annual growth rate (CAGR) of 6.2%. This escalated expansion during the forecast period is primarily ascribed to the increasing air pollution levels, growing elderly population, raised healthcare awareness, emerging trends of personalized medicine, and groundbreaking progress in biopharmaceuticals. The prominent and pivotal trends predicted for this period comprise therapies involving small molecules, home-centric asthma treatments, therapies guided by biomarkers, novel therapeutic advancements for severe asthma, and cooperative asthma researches.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11924

What Are the Latest Innovations Influencing theAsthma Drugs Market?

Leading companies in the asthma drugs market are concentrating on developing innovative solutions like fixed-dose combination (FDC) drugs to improve treatment effectiveness and patient compliance. A fixed-dose combination (FDC) drug is a single-dosage medication that is comprised of two or more active components, such as a capsule, tablet, or inhaler. For example, Glenmark Pharmaceuticals, a company based in India, introduced Indamet, an FDC drug for individuals with uncontrolled asthma, in June 2022. This groundbreaking treatment combines Indacaterol, which is a long-term beta-agonist, and Mometasone Furoate, which is an inhaled corticosteroid, and it is available in a variety of strengths, including Indacaterol 150 mcg paired with Mometasone at 80 mcg, 160 mcg, and 320 mcg. Indamet is intended for once-daily usage and targets adolescents and adults who are 12 years of age and older.

Who Are the Major Industry Players Accelerating Growth in theAsthma Drugs Market?

Major companies operating in the asthma drugs market include Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC., GlaxoSmithKline PLC., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Novartis International AG, Mylan N.V., Cipla Limited, Chiesi Farmaceutici S.p.A., Sun Pharmaceutical Industries Limited, Hikma Pharmaceuticals, Mundipharma International Limited, Lupin Limited, Glenmark Pharmaceuticals Limited, Hetero Drugs Limited, Alembic Pharmaceuticals Limited, Sunovion Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc., Beximco Pharmaceuticals Ltd, Innoviva Inc., Vectura Group, Circassia Group PLC, Pulmatrix Inc., Atopix Therapeutics Limited

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

Which Primary Segments of the Asthma Drugs Market Are Driving Growth and Industry Transformations?

The asthma drugs market covered in this report is segmented –

1) By Type Of Asthma: Allergic, Non-Allergic

2) By Asthma Trigger Type: Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Nocturnal Asthma, Steroid-Resistant Asthma

3) By Therapy: Preventive, Curative

4) By Drug Class: Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs

5) By End-User: Asthma Patients, COPD Patients

Subsegments:

1) By Allergic: Inhaled Corticosteroids (ICS), Leukotriene Receptor Antagonists (LTRAs), Monoclonal Antibodies

2) By Non-Allergic: Short-Acting Beta Agonists (SABAs), Long-Acting Beta Agonists (LABAs), Oral Corticosteroids

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=11924&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theAsthma Drugs Market?# Market?

North America was the largest region in the asthma drugs market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Gobal Asthma Drugs Maret 2025, By The Business Research Company:

Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Delivery Drones Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/delivery-drones-global-market-report

Drugs For Erectile Dysfunction Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drugs-for-erectile-dysfunction-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: